- ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
- ENDRA Life Sciences to Report Fourth Quarter 2023 Financial Results on March 28, 2024
- ENDRA Life Sciences Installs First TAEUS System in the UK
- New ICD-10-CM Code by the World Health Organization Paves the Way for Improved NAFLD Diagnostics Including ENDRA Life Sciences’ TAEUS System
- ENDRA Life Sciences Bolsters TAEUS® System Intellectual Property with New Patents in U.S., China and Europe
More ▼
Key statistics
On Friday, ENDRA Life Sciences Inc (NDRA:NAQ) closed at 0.2525, 14.25% above the 52 week low of 0.221 set on Apr 17, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.252 |
---|---|
High | 0.2573 |
Low | 0.2422 |
Bid | 0.2476 |
Offer | 0.26 |
Previous close | 0.2425 |
Average volume | 104.80k |
---|---|
Shares outstanding | 11.04m |
Free float | 10.69m |
P/E (TTM) | -- |
Market cap | 2.68m USD |
EPS (TTM) | -1.93 USD |
Data delayed at least 15 minutes, as of Apr 26 2024 20:57 BST.
More ▼